PostEra

PostEra is an AI-driven biopharma company based in Boston, founded in 2019. The company focuses on accelerating medicinal chemistry and drug discovery through its advanced machine learning platform, Proton. This technology enhances the discovery of new medicines by optimizing the design and development of small molecule drug candidates. PostEra develops its own drug candidates and engages in co-discovery partnerships with major pharmaceutical companies, including Amgen and Pfizer, as well as the National Institutes of Health (NIH). The company has led significant initiatives, such as the COVID Moonshot, aimed at accelerating antiviral treatment discovery. Its internal pipeline targets therapeutic areas like Women's Health and Fertility, while also collaborating on various preclinical programs.

Research Boston, United States ~39 employees Private · Series A

Work at PostEra in HR or recruiting? Claim this page

Employees
39
+2.6% in the 3 months to Sep 2026
Total funding
$50.2M
Last round Series A, Jan 2022
12-month attrition
4.1%
Tech: 4.2%
H1B sponsor
NA

Headcount trend

PostEra went from 34 employees in Oct 2024 to 39 in Sep 2026. Apr to Sep 2026: 1 people joined, 1 left.

Funding rounds

Total funding$50.2M
Funding rounds3
Investors8
DateRoundMoney raisedNo.Investors
Jan 2022Series A$24M8
Dec 2021Funding$26.1M––
Mar 2020Seed$150K––

Org structure

Headcount by department

Other23
Engineering11
Operations2
Finance1
HR1
Design1

PostEra FAQ

How many employees does PostEra have?

PostEra has about 39 employees, up 2.6% over the 3 months to Sep 2026.

How much funding has PostEra raised?

PostEra has raised $50.2M in total funding; its latest round was Series A in Jan 2022.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.